Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

New Analysis Suggests Aubagio® (teriflunomide) Slows Brain Atrophy in People with Relapsing Multiple Sclerosis
Painful Tonic Spasm in Neuromyelitis Optica: Incidence, Diagnostic Utility, and Clinical Characteristics.
Inflammation-mediated memory dysfunction and effects of a ketogenic diet in a murine model of multiple sclerosis.
Epistasis and immunity: the role of genetic interactions in autoimmune diseases.
Teva to initiate third Phase III trial of oral laquinimod for the treatment of relapsing remitting multiple sclerosis
Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial.
Multiple sclerosis disease-modifying therapy prescribing patterns in ontario.
The chemokine receptor CCR5 Δ32 allele in natalizumab-treated multiple sclerosis.
Vaccines and the Risk of Multiple Sclerosis and Other Central Nervous System Demyelinating Diseases.
▼Dimethyl fumarate for relapsing-remitting multiple sclerosis.
Building a better sphingosine kinase-1 inhibitor.
The impact of environmental infections (parasites) on MS activity.
Changed histone acetylation patterns in normal-appearing white matter and early multiple sclerosis lesions.
Patient Perspectives and Experience with Dalfampridine Treatment in Multiple Sclerosis-Related Walking Impairment: The Step Together Program.
Cerebrospinal fluid biomarkers of β-amyloid metabolism in multiple sclerosis.
Phenytoin protects central axons in experimental autoimmune encephalomyelitis.
B-57The Temporal Onset of Cognitive Fatigue in Multiple Sclerosis.
Multiple sclerosis: Spinal cord grey matter loss correlates with disability in MS.
Pediatric multiple sclerosis in Venezuela.
Implication of perturbed axoglial apparatus in early pediatric multiple sclerosis.
Mortality statistics for multiple sclerosis and amyotrophic lateral sclerosis in sweden.
Update on PML and PML-IRIS Occurring in Multiple Sclerosis Patients Treated With Natalizumab.
Reward responsiveness and fatigue in multiple sclerosis.
Biologics at Novartis
Human autoimmunity after lymphocyte depletion is caused by homeostatic T-cell proliferation.

Pages